Personally, i am finished with buying this stock anymore. They need to show us that they can build a solid product and then sell it to someone else other than touchstone.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025